Praxis develops neurology drugs for movement disorders.
Praxis Precision Medicines, Inc. (PRAX) is expected to report earnings on Wednesday, November 4, 2026, before the open. Estimated release time 08:33 ET. Consensus EPS estimate is $-3.53.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-06 | Jun 2026 qtr | $-3.67 | $-2.87 | +21.8% | $0 |
| 2025-02-28 | Dec 2024 qtr | $-2.76 | $-2.94 | -6.5% | — |
| 2024-11-06 | Sep 2024 qtr | $-2.01 | $-2.75 | — | $302.00K |
| 2024-08-13 | Jun 2024 qtr | $-2.38 | $-1.74 | — | $357.00K |
| 2024-05-13 | Mar 2024 qtr | $-2.01 | $-2.84 | — | $431.00K |
| 2024-03-05 | Dec 2023 qtr | $-3.15 | $-2.97 | +5.7% | — |
| 2023-11-07 | Sep 2023 qtr | $-5.25 | $-2.72 | — | $468.00K |
| 2023-08-09 | Jun 2023 qtr | $-9.90 | $-7.38 | — | $781.00K |
PRAX has beaten consensus EPS in 2 of its last 3 scored quarters.
See PRAX on the live calendar →